Clinical Trial Update: A Study of Mirabegron (YM178) in Men With Lower Urinary Tract Symptoms (LUTS) and Bladder Outlet Obstruction (BOO) [Phase 2]

View source ↗

Summary

Phase 2 study of Mirabegron (YM178) in men with lower urinary tract symptoms and bladder outlet obstruction completed with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Outlet Obstruction
• Lower Urinary Tract Symptoms

Drugs mentioned

• Myrbetriq (mirabegron)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Lower Urinary Tract Symptoms, Bladder Outlet Obstruction | Phase 2 | Status: COMPLETED | Results posted: 2012-09-05